Epidemiological studies regarding hypertensive disorders of pregnancy: A review.
cardiovascular
fetal growth restriction
pre-eclampsia/eclampsia
renal and hypertension
research design/epidemiology and statistics
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
29
05
2020
accepted:
12
06
2020
pubmed:
28
7
2020
medline:
22
6
2021
entrez:
28
7
2020
Statut:
ppublish
Résumé
A hypertensive disorder of pregnancy (HDP) is defined as hypertension emerging after 20 weeks of gestation and resolving up to 12 weeks post-partum, and occurs in about 5% of all pregnancies. Complications associated with HDP have poor prognoses, and maternal deaths attributable to HDP are predicted to exceed 70 000 per year worldwide. Understanding the pathogenesis and risk factors of hypertensive disorders of pregnancy is important, and they are often investigated in observational studies. Given that therapeutic interventions cannot be controlled in observed studies, it is necessary to interpret which factors correspond to exposure and which factors correspond to confounding and intermediate factors in each study. From the Babies and their parents' longitudinal observation in the Suzuki Memorial Hospital on Intrauterine period study, blood pressure in early pregnancy was not only predictive of a child's birthweight, but the trajectory was also associated with the birthweight. From the larger-scale birth cohort studies currently conducted in Japan will provide the novel potential risk factors of hypertensive disorders of pregnancy and preventive strategies of them. In Japan, observational or intervention studies are just beginning to emerge. The continuation of both a distinctive cohort and a large cohort is needed, and the development of good quality intervention trials based on the results of observational studies is important.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1672-1677Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP19gk0110039
Organisme : Ministry of Health, Labour and Welfare
ID : 19DA1001
Organisme : Japan Society for the Promotion of Science
ID : 18590587
Organisme : Japan Society for the Promotion of Science
ID : 18390192
Organisme : Japan Society for the Promotion of Science
ID : 21390201
Organisme : Japan Society for the Promotion of Science
ID : 24689061
Organisme : Japan Society for the Promotion of Science
ID : 25253059
Organisme : Japan Society for the Promotion of Science
ID : 19K18628
Organisme : Japan Society for the Promotion of Science
ID : 19.7152
Organisme : Japan Society for the Promotion of Science
ID : 20.7198
Organisme : Japan Society for the Promotion of Science
ID : 20.7477
Organisme : Japan Society for the Promotion of Science
ID : 20.54043
Organisme : Japan Society for the Promotion of Science
ID : 26860412
Organisme : Japan Society for the Promotion of Science
ID : 16H05243
Organisme : Japan Society for the Promotion of Science
ID : 17K15857
Organisme : Japan Society for the Promotion of Science
ID : 18K15837
Organisme : Japan Society for the Promotion of Science
ID : 19H03905
Informations de copyright
© 2020 Japan Society of Obstetrics and Gynecology.
Références
Watanabe K, Naruse K, Tanaka K, Metoki H, Suzuki Y. Outline of definition and classification of “pregnancy induced hypertension (PIH)”. Hypertens Res Preg 2013; 1: 3-4.
Brown MA, Magee LA, Kenny LC et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2018; 13: 291-310.
Dachew BA, Scott JG, Mamun A, Alati R. Pre-eclampsia and the risk of attention-deficit/hyperactivity disorder in offspring: Findings from the ALSPAC birth cohort study. Psychiatry Res 2019; 272: 392-397.
Maher GM, O'Keeffe GW, Kearney PM et al. Association of hypertensive disorders of pregnancy with risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. JAMA Psychiat 2018; 75: 809-819.
Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 564-567.
Rasmussen S, Irgens LM. Pregnancy-induced hypertension in women who were born small. Hypertension 2007; 49: 806-812.
Metoki H, Ohkubo T, Watanabe Y et al. Seasonal trends of blood pressure during pregnancy in Japan: The babies and their parents' longitudinal observation in Suzuki memorial Hospital in Intrauterine Period study. J Hypertens 2006; 26: 2406-2413.
Metoki H, Ohkubo T, Obara T et al. Daily serial hemodynamic data during pregnancy and seasonal variation: The BOSHI study. Clin Exp Hypertens 2012; 34: 290-296.
Satoh M, Tanno Y, Hosaka M et al. Salt intake and the validity of a salt intake assessment system based on a 24-h dietary recall method in pregnant Japanese women. Clin Exp Hypertens 2015; 37: 459-462.
Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. Br J Obstet Gynecol 2005; 112: 601-606.
Ishikuro M, Obara T, Metoki H et al. Blood pressure measured in the clinic and at home during pregnancy among nulliparous and multiparous women: The BOSHI study. Am J Hypertens 2013; 26: 141-148.
Ishikuro M, Obara T, Metoki H et al. Parity as a factor affecting the white-coat effect in pregnant women: The BOSHI study. Hypertens Res 2015; 38: 770-775.
Iwama N, Metoki H, Ohkubo T et al. Maternal clinic and home blood pressure measurements during pregnancy and infant birthweight: The BOSHI study. Hypertens Res 2016; 39: 151-157.
Iwama N, Oba M, Satoh M et al. Association of maternal home blood pressure trajectory during pregnancy with infant birthweight: The BOSHI study. Hypertens Res 2020; 43: 1-10.
Oba MS, Murakami Y, Satoh M et al. Examining the trimester-specific effects of low gestational weight gain on birthweight: The BOSHI study. J Dev Orig Health Dis 2020; in press.
Iwama N, Metoki H, Nishigori H et al. Blood pressure changes during twin pregnancies: The Japan environment and Children's study. J Hypertens 2019; 37: 206-215.
Iwama N, Metoki H, Nishigori H et al. Association between alcohol consumption during pregnancy and hypertensive disorders of pregnancy in Japan: The Japan environment and Children's study. Hypertens Res 2019; 42: 85-94.
Tanaka K, Nishigori H, Watanabe Z et al. Higher prevalence of hypertensive disorders of pregnancy in women who smoke: The Japan environment and children's study. Hypertens Res 2019; 42: 558-566.
Kuriyama S, Metoki H, Kikuya M et al. Cohort profile: Tohoku medical megabank project birth and three-generation cohort study (TMM BirThree cohort study): Rationale, progress and perspective. Int J Epidemiol 2020; 49: 18-19m.
Poon LC, Kametas NA, Maiz N et al. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.
Rolnik DL, Wright D, Poon LC et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377: 613-622.